Gene: ZFP82
Official Full Name: ZFP82 zinc finger proteinprovided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12386 | ZFP82 Knockout cell line (HeLa) | Human | ZFP82 | 1:3~1:6 | Negative | Online Inquiry |
KO12387 | ZFP82 Knockout cell line (HEK293) | Human | ZFP82 | 1:3~1:6 | Negative | Online Inquiry |
KO12388 | ZFP82 Knockout cell line (A549) | Human | ZFP82 | 1:3~1:4 | Negative | Online Inquiry |
ZFP82 Gene Knockout Cell Lines are specifically engineered cellular models that lack the expression of the ZFP82 gene, allowing researchers to explore the biological role of this particular gene in various cellular processes. Utilizing advanced CRISPR-Cas9 genome editing technology, these cell lines are designed to provide a powerful tool for functional genomics and therapeutic research, facilitating the dissection of gene function, regulatory pathways, and potential disease mechanisms.
The primary function of ZFP82 Gene Knockout Cell Lines centers around the study of gene interactions and cellular responses within a controlled environment. By knocking out the ZFP82 gene, researchers can observe changes in cellular behavior, including alterations in proliferation, differentiation, and signaling pathways. This can lead to insights into the gene’s role in development and disease states, such as cancer or metabolic disorders.
In terms of scientific importance, these cell lines serve as invaluable resources in both research and clinical settings. They enable scientists to generate targeted hypotheses regarding gene function, model disease phenotypes, and screen for potential therapeutic targets. The specificity of the knockout allows for the examination of precise biological questions, thereby accelerating the discovery of novel treatments or interventions.
One unique selling point of our ZFP82 Gene Knockout Cell Lines is their high fidelity and reproducibility. Each cell line is validated for consistent knockout efficiency and off-target effects are minimized, surpassing many alternative models that may introduce variability. Additionally, the ease of use with standard culture practices makes these cell lines accessible for both experienced researchers and those new to genetic manipulation techniques.
For researchers, clinicians, and pharmaceutical companies aiming to unveil the underlying mechanisms of disease or to evaluate gene-targeting strategies, ZFP82 Gene Knockout Cell Lines offer a robust platform for innovative research. Their capacity to provide clear experimental endpoints positions them as key assets in the toolbox of molecular biology.
Our company is committed to facilitating cutting-edge research through high-quality biological products, supported by extensive expertise and innovation in genetic engineering. We pride ourselves on delivering reliable and user-friendly solutions that enable our partners to push the boundaries of scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.